Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-10 09:48 am Sale | 13G | CLOVIS ONCOLOGY INC CLVS | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 5,921,695 3.92% | -5,134,534 (-46.44%) | View |
| 2022-07-08 4:56 pm Sale | 13G | CLOVIS ONCOLOGY INC CLVS | BlackRock Inc. BLK | 4,755,365 3.3% | -4,995,912 (-51.23%) | View |
| 2022-04-11 1:58 pm Sale | 13G | CLOVIS ONCOLOGY INC CLVS | STATE STREET CORP STT | 2,619,477 1.84% | -13,495,065 (-83.74%) | View |
| 2022-03-11 2:13 pm Unchanged | 13G | CLOVIS ONCOLOGY INC CLVS | BlackRock Inc. BLK | 9,751,277 7.5% | 0 (Unchanged) | View |
| 2022-02-14 4:59 pm Sale | 13G | CLOVIS ONCOLOGY INC CLVS | Palo Alto Investors LP | 3,997,826 3.08% | -471,585 (-10.55%) | View |
| 2022-02-11 08:18 am Purchase | 13G | CLOVIS ONCOLOGY INC CLVS | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 11,056,229 7.84% | 1,147,989 (+11.59%) | View |
| 2022-02-11 07:57 am Purchase | 13G | CLOVIS ONCOLOGY INC CLVS | STATE STREET CORP STT | 16,114,542 12.4% | 5,655,198 (+54.07%) | View |
| 2022-02-09 3:43 pm Sale | 13G | CLOVIS ONCOLOGY INC CLVS | VANGUARD GROUP INC | 10,115,101 7.78% | -2,179,790 (-17.73%) | View |
| 2022-02-08 5:05 pm Purchase | 13G | CLOVIS ONCOLOGY INC CLVS | BlackRock Inc. BLK | 9,751,277 7.5% | 2,890,045 (+42.12%) | View |
| 2021-10-12 09:29 am Purchase | 13G | CLOVIS ONCOLOGY INC CLVS | VANGUARD GROUP INC | 12,294,891 10.38% | 5,907,337 (+92.48%) | View |
| 2021-06-10 10:13 am Purchase | 13G | CLOVIS ONCOLOGY INC CLVS | STATE STREET CORP STT | 10,459,344 10% | 566,467 (+5.73%) | View |
| 2021-04-12 11:52 am Sale | 13G | CLOVIS ONCOLOGY INC CLVS | STATE STREET CORP STT | 9,892,877 9.46% | -4,642,995 (-31.94%) | View |
| 2021-02-16 4:30 pm Sale | 13G | CLOVIS ONCOLOGY INC CLVS | CITADEL ADVISORS LLC | 2,194,035 2.1% | -1,198,589 (-35.33%) | View |
| 2021-02-16 4:29 pm Sale | 13G | CLOVIS ONCOLOGY INC CLVS | Palo Alto Investors LP | 4,469,411 5.06% | -586,875 (-11.61%) | View |
| 2021-02-16 4:11 pm Sale | 13G | CLOVIS ONCOLOGY INC CLVS | Redmile Group LLC | 0 0% | -3,430,529 (Position Closed) | View |
| 2021-02-16 2:56 pm Sale | 13G | CLOVIS ONCOLOGY INC CLVS | WHITEBOX ADVISORS LLC | 1,276,152 1.2% | -3,237,834 (-71.73%) | View |
| 2021-02-16 1:45 pm Sale | 13G | CLOVIS ONCOLOGY INC CLVS | Capital World Investors | 0 0% | -3,443,000 (Position Closed) | View |
| 2021-02-12 4:21 pm Purchase | 13G | CLOVIS ONCOLOGY INC CLVS | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 9,908,240 8.74% | 5,354,172 (+117.57%) | View |
| 2021-02-11 2:38 pm Unchanged | 13G | CLOVIS ONCOLOGY INC CLVS | STATE STREET CORP STT | 14,535,872 16.46% | 0 (Unchanged) | View |
| 2021-02-10 10:46 am Purchase | 13G | CLOVIS ONCOLOGY INC CLVS | VANGUARD GROUP INC | 6,387,554 7.23% | 2,169,210 (+51.42%) | View |